CR011-vcMMAE: Additional Phase I/II data

Additional data from 36 patients in the open-label Phase II portion of an ongoing U.S. Phase I/II trial showed that IV CR011-vcMMAE produced 3 partial responses (PR), 1 unconfirmed PR and 19 cases of ...